天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

ChemicalBook >> CAS DataBase List >>Insulin-like Growth Factor-1 Receptor Inhibitor

Insulin-like Growth Factor-1 Receptor Inhibitor

CAS No.
468740-43-4
Chemical Name:
Insulin-like Growth Factor-1 Receptor Inhibitor
Synonyms
CS-469;CS-0117;HY-10262;BMS-536924;BMS-536924, >=98%;BMS-536924 (CS0117;BMS 536924;BMS536924;BMS-536924 >=98% (HPLC);BMS-536924, 10 mM in DMSO;BMS-536924(HY-10262, CS-0117)
CBNumber:
CB22510062
Molecular Formula:
C25H26ClN5O3
Molecular Weight:
479.96
MDL Number:
MFCD14635360
MOL File:
468740-43-4.mol
MSDS File:
SDS
Last updated:2025-04-17 18:22:24

Insulin-like Growth Factor-1 Receptor Inhibitor Properties

Melting point >206°C (dec.)
Density 1.44
storage temp. Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
solubility DMSO (Slightly)
pka 10.40±0.10(Predicted)
form Solid
color Light Yellow to Yellow
CAS DataBase Reference 468740-43-4
FDA UNII 40E3AZG1MX

Insulin-like Growth Factor-1 Receptor Inhibitor price More Price(25)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Cayman Chemical 14666 BMS-536924 ≥98% 468740-43-4 1mg $49 2024-03-01 Buy
Cayman Chemical 14666 BMS-536924 ≥98% 468740-43-4 5mg $190 2024-03-01 Buy
Cayman Chemical 14666 BMS-536924 ≥98% 468740-43-4 10mg $286 2024-03-01 Buy
Cayman Chemical 14666 BMS-536924 ≥98% 468740-43-4 25mg $651 2024-03-01 Buy
Tocris 4774 BMS536924 ≥98%(HPLC) 468740-43-4 10 $292 2021-12-16 Buy
Product number Packaging Price Buy
14666 1mg $49 Buy
14666 5mg $190 Buy
14666 10mg $286 Buy
14666 25mg $651 Buy
4774 10 $292 Buy

Insulin-like Growth Factor-1 Receptor Inhibitor Chemical Properties,Uses,Production

Uses

BMS 536924 is an inhibitor of insulin-like growth factor receptor (IGF1R) kinase and insulin receptor. BMS 536924 was reported to have antitumor activity.

Definition

ChEBI: 4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-(4-morpholinyl)-1,3-dihydrobenzimidazol-2-ylidene]-2-pyridinone is a member of benzimidazoles.

in vivo

BMS-536924 (100 mg/kg; gavage; daily; for 35 days) causes regression of xenografts in vivo and an average reduction of 76% tumor volume after 2 weeks[2].

Animal Model:Athymic nude mice with CD8-IGF-IRMCF10A cells[2]
Dosage:100 mg/kg
Administration:Gavage; daily; for 35 days
Result:Caused an average reduction of 76% tumor volume after 2 weeks.

storage

Store at -20°C

Insulin-like Growth Factor-1 Receptor Inhibitor Preparation Products And Raw materials

Raw materials

Preparation Products

Global( 114)Suppliers
Supplier Tel Email Country ProdList Advantage
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795 ivan@atkchemical.com China 33024 60
Hubei xin bonus chemical co. LTD
86-13657291602 linda@hubeijusheng.com CHINA 22963 58
CONIER CHEM AND PHARMA LIMITED
+8618523575427 sales@conier.com China 49732 58
career henan chemical co
+86-0371-86658258 +8613203830695 factory@coreychem.com China 29807 58
Dideu Industries Group Limited
+86-29-89586680 +86-15129568250 1026@dideu.com China 22866 58
Zhejiang J&C Biological Technology Co.,Limited
+1-2135480471 +1-2135480471 sales@sarms4muscle.com China 10473 58
InvivoChem
+1-708-310-1919 +1-13798911105 sales@invivochem.cn United States 6391 58
LEAP CHEM CO., LTD.
+86-852-30606658 market18@leapchem.com China 24727 58
TargetMol Chemicals Inc.
support@targetmol.com United States 38668 58
ShenZhen Trendseen Biological Technology Co.,Ltd.
13417589054 trendseenbio@gmail.com China 11681 58

View Lastest Price from Insulin-like Growth Factor-1 Receptor Inhibitor manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
Insulin-like Growth Factor-1 Receptor Inhibitor pictures 2020-01-13 Insulin-like Growth Factor-1 Receptor Inhibitor
468740-43-4
US $9.80 / KG 1KG ≥98% 20 tons Career Henan Chemical Co
Insulin-like Growth Factor-1 Receptor Inhibitor pictures 2020-01-13 Insulin-like Growth Factor-1 Receptor Inhibitor
468740-43-4
US $9.80 / KG 1KG ≥98% 20 tons Career Henan Chemical Co

Insulin-like Growth Factor-1 Receptor Inhibitor Spectrum

4-[[(2S)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino]-3-[7-methyl-5-(4-morpholinyl)-1H-benzimidazol-2-yl]-2(1H)-pyridinone BMS-536924 Insulin-like Growth Factor-1 Receptor Inhibitor 4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[4-methyl-6-(4-morpholinyl)-1H-benzimidazol-2-yl]- 2(1H)-pyridinone CS-0117 HY-10262 BMS-536924 Insulin-like Growth Factor-1 Receptor Inhibitor BMS-536924, >=98% 4-[[(2S)-2-(3-Chlorophenyl)-2-hydroxyethyl]aMino]-3-[7-Methyl-5-(4-Morpholinyl)-1H-benziMidazol-2-yl]-2(1H)-pyridinone BMS-536924 CS-469 BMS 536924;BMS536924 (S)-4-[2-(3-Chloro-phenyl)-2-hydroxy-ethylamino]-3-(4-methyl-6-morpholin-4-yl-1H-benzoimidazol-2-yl)-1H-pyridin-2-one BMS-536924(HY-10262, CS-0117) 2(1H)-Pyridinone, 4-[[(2S)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]-3-[7-methyl-5-(4-morpholinyl)-1H-benzimidazol-2-yl]- BMS-536924 >=98% (HPLC) Insulin-like Growth Factor-1 Receptor Inhibitor USP/EP/BP (S)-4-((2-(3-Chlorophenyl)-2-hydroxyethyl)amino)-3-(4-methyl-6-morpholino-1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-one BMS-536924 (CS0117 Insulin-like Growth Factor-1 Receptor Inhibito BMS-536924, 10 mM in DMSO 468740-43-4 C25H26ClN5O3 Inhibitors